RecruitingNCT07696572
EUS Procedures Using RIVOS™ EUS Access Device
Registry of Patients Undergoing Endoscopic Ultrasound (EUS) Procedures Using the RIVOS™ EUS Access Device
Sponsor
Orlando Health, Inc.
Enrollment
30 participants
Start Date
Jul 1, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying EUS-guided intervention using the RIVOS™ EUS access device for people with biliary obstruction, chronic pancreatitis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEEUS-guided intervention using the RIVOS™ EUS access device
EUS-guided intervention using the RIVOS™ EUS access device
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07696572
Related Trials
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
NCT0665158026 locations
Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis
NCT074185932 locations
QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
NCT034343922 locations
CREO - Microwave Ablation Feasibility Study
NCT07817147
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
NCT049966283 locations